Novartis AG Strikes a Game-Changing $1.7 Billion Deal to Acquire Regulus Therapeutics Inc.

Novartis AG has entered into a groundbreaking agreement to acquire Regulus Therapeutics Inc. for up to $1.7 billion, including an initial $0.8 billion payment and potential future ...